Clinical trials
Withdrawn Stomach Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Antonios Likourezos | 1 |
| Artiva Biotherapeutics, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| City of Hope Medical Center | 1 |
| Eastern Cooperative Oncology Group | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| ImmunoGen, Inc. | 1 |
| Massachusetts General Hospital | 1 |
| Mayo Clinic | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 17 |
| Pancreatic Neoplasms | 5 |
| Esophageal Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Colonic Neoplasms | 3 |
| Colorectal Neoplasms | 3 |
| Gastrointestinal Neoplasms | 3 |
| Neoplasms | 3 |
| Adenocarcinoma | 2 |
| Neoplasm Metastasis | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.